Assignee
KUDOS PHARM LTD
GB·30 granted patents·12 pending applications·257 citations·filing 1998–2024
Top patents by PatentIndex Score
42 records- 0197US7449464B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2004·Granted Nov 11, 2008·69 cites·2 claims
- 0296US11633396B2Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-oneKUDOS PHARM LTD·Filed 2022·Granted Apr 25, 2023·8 cites·30 claims
- 0395US7662818B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2005·Granted Feb 16, 2010·20 cites·7 claims
- 0491US7981889B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2008·Granted Jul 19, 2011·17 cites·9 claims
- 0591US7692006B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2007·Granted Apr 6, 2010·28 cites·7 claims
- 0691US7504397B2mTOR inhibitor compoundsKUDOS PHARM LTD·Filed 2006·Granted Mar 17, 2009·12 cites·14 claims
- 0790US12178816B2Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2024·Granted Dec 31, 2024·0 cites·30 claims
- 0890US12144810B1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2024·Granted Nov 19, 2024·0 cites·30 claims
- 0990US9102670B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2013·Granted Aug 11, 2015·5 cites·6 claims
- 1090US7402607B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2005·Granted Jul 22, 2008·16 cites·13 claims
- 1188US7750006B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2006·Granted Jul 6, 2010·7 cites·2 claims
- 1287US9566276B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2015·Granted Feb 14, 2017·4 cites·12 claims
- 1387US7470688B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2006·Granted Dec 30, 2008·10 cites·14 claims
- 1486US12048695B2Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2023·Granted Jul 30, 2024·0 cites·10 claims
- 1586US11975001B2Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2023·Granted May 7, 2024·0 cites·13 claims
- 1686US9169235B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2014·Granted Oct 27, 2015·5 cites·12 claims
- 1785US7049313B2ATM inhibitorsKUDOS PHARM LTD·Filed 2003·Granted May 23, 2006·19 cites·9 claims
- 1884US10449192B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2018·Granted Oct 22, 2019·2 cites·4 claims
- 1979US11160803B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2019·Granted Nov 2, 2021·0 cites·9 claims
- 2078US2022249474A1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-oneKUDOS PHARM LTD·Filed 2021·Application pending·0 cites
- 2177US7696203B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2006·Granted Apr 13, 2010·4 cites·9 claims
- 2270US7429660B2ATM inhibitorsKUDOS PHARM LTD·Filed 2004·Granted Sep 30, 2008·4 cites·12 claims
- 2370US6753151B1Interactions of Ku polypeptides and applications thereofKUDOS PHARM LTD·Filed 2000·Granted Jun 22, 2004·9 cites·10 claims
- 2465US10034884B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2017·Granted Jul 31, 2018·0 cites·4 claims
- 2562US2017226124A1Phthalazinone derivativesKUDOS PHARM LTD·Filed 2017·Application pending·0 cites
- 2660US7902193B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2008·Granted Mar 8, 2011·0 cites·14 claims
- 2758US9717736B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2015·Granted Aug 1, 2017·0 cites·4 claims
- 2858US7732483B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2008·Granted Jun 8, 2010·0 cites·11 claims
- 2958US2009043091A1Atm inhibitorsKUDOS PHARM LTD·Filed 2008·Application pending·0 cites
- 3058US2023015617A1Phthalazinone derivativesKUDOS PHARM LTD·Filed 2021·Application pending·0 cites
- 3151US7642254B2ATM inhibitorsKUDOS PHARM LTD·Filed 2006·Granted Jan 5, 2010·0 cites·3 claims
- 3247US2007049588A1Atm inhibitorKUDOS PHARM LTD·Filed 2006·Application pending·0 cites
- 3346US2009181951A1Parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 3446US2009281086A12 -oxyheteroarylamide derivatives as parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 3546US2009209520A12 -oxybenzamide derivatives as parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 3645US2008194546A1Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR InhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 3743US2006199803A1CompoundsKUDOS PHARM LTD·Filed 2006·Application pending·0 cites
- 3843US2006135770A1PARP inhibitorsKUDOS PHARM LTD·Filed 2005·Application pending·0 cites
- 3941US7138236B1Interactions of ATM, ATR or DAN-PK with p53KUDOS PHARM LTD·Filed 1998·Granted Nov 21, 2006·6 cites·2 claims
- 4036US2007161808A1Process for the preparation of aq4nKUDOS PHARM LTD·Filed 2005·Application pending·0 cites
- 4134US6242175B1Methods and means relating to retrotransposon and retroviral integrationKUDOS PHARM LTD·Filed 1998·Granted Jun 5, 2001·8 cites·15 claims
- 4227US6753158B1Assays, agents, therapy and diagnosis relating to modulation of cellular DNA repair activityKUDOS PHARM LTD·Filed 1998·Granted Jun 22, 2004·4 cites·3 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →